Related Experiment Video
Updated: Sep 1, 2025

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma
Luhao Li1, Suxin Li1, Haohao Wang1
1Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of Zhengzhou University, No. 1 East Jianshe Road, Zhengzhou, Henan, 450052, China.
Background:
Hepatocellular carcinoma (HCC) is one of the most commonly diagnosed malignant tumors in the world. In recent years, more and more inhibitors against gene targets have been found to be beneficial to survival. However, the function of homo-sapiens histone H3 associated protein kinase (GSG2) in HCC has not been completely understood.
Methods:
The expression of GSG2 in HCC tissues was detected by immunohistochemical staining. The lentivirus-mediated short hairpin RNA (shRNA) was used to knockdown GSG2 expression in HCC cell lines Hep3B2.1-7 and SK-HEP-1. Cell proliferation and colony formation were detected by MTT assay and colony formation assay, respectively, and flow cytometry assay was used to investigate the cell apoptosis in vitro. Mice xenograft model was constructed to detect the functions of GSG2 on tumor growth in vivo. Human Apoptosis Antibody Array was conducted to find the possible mechanism.
Results:
GSG2 was overexpressed in HCC tissues compared with adjacent normal tissues. The knockdown of GSG2 had the functions of inhibiting the progression of HCC, including inhibiting cell proliferation and colony formation and promoting cell apoptosis. Compared with shCtrl group, the shGSG2 group expressed higher apoptotic genes such as caspase 3, caspase 8, Fas and FasL, while lower IGF1, Bcl2 and Bcl-w.
Conclusions:
Our study showed that knockdown of GSG2 suppresses the tumor growth in vitro and vivo. Therefore, GSG2 might play an oncogenic role in HCC.
Insights
Homo-sapiens histone H3 associated protein kinase (GSG2) is overexpressed in hepatocellular carcinoma (HCC). Knocking down GSG2 inhibits HCC progression and tumor growth, suggesting GSG2 plays an oncogenic role in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a prevalent malignancy worldwide.
- Targeted therapies are improving survival rates in cancer patients.
- The specific role of homo-sapiens histone H3 associated protein kinase (GSG2) in HCC remains unclear.
Purpose of the Study:
- To investigate the expression and function of GSG2 in hepatocellular carcinoma.
- To determine the impact of GSG2 on HCC cell proliferation, apoptosis, and tumor growth.
- To elucidate the potential oncogenic role of GSG2 in HCC development.
Main Methods:
- Immunohistochemical staining to detect GSG2 expression in HCC tissues.
- GSG2 knockdown using lentivirus-mediated short hairpin RNA (shRNA) in HCC cell lines.
- In vitro assays (MTT, colony formation, flow cytometry) and in vivo mice xenograft model to assess tumor growth and apoptosis.
- Human Apoptosis Antibody Array to explore underlying mechanisms.
Main Results:
- GSG2 was significantly overexpressed in HCC tissues compared to adjacent normal tissues.
- GSG2 knockdown inhibited HCC cell proliferation and colony formation in vitro.
- GSG2 knockdown promoted apoptosis, evidenced by increased caspase 3, caspase 8, Fas, and FasL expression, and decreased IGF1, Bcl2, and Bcl-w.
- Inhibition of GSG2 suppressed tumor growth in vivo.
Conclusions:
- GSG2 knockdown effectively suppresses tumor growth in both in vitro and in vivo models of HCC.
- GSG2 appears to play a crucial oncogenic role in the progression of hepatocellular carcinoma.
- Targeting GSG2 may represent a potential therapeutic strategy for HCC treatment.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018
Related Concept Videos
Mitogens and the Cell Cycle
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Inhibition of Cdk Activity
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
TGF - β Signaling Pathway